A guy studying improv, flow, psychedelics, and creativity 🧠 šŸ„ šŸŽµ | Postdoc @JHPsychedelics | Dad, Bassist, Pianist, Yogi, Educator

Philadelphia, PA
Joined February 2018
NEW RESEARCH: The Neuroscience of Creative Flow in Jazz Improvisation: An EEG Study 🧠 šŸŽµ šŸ—£ļø Delve into the secrets of creative flow in jazz improvisation and how experience affects these altered states of consciousness. Read the full paper here: sciencedirect.com/science/ar…
4
24
9
72
13,931
David S. Rosen, PhD retweeted
Me: I try to look at data and trends rather than headlines, because headlines can give you a misleading picture of the state of the world. Something goes wrong every day — that’s guaranteed — and if you just look at something goes wrong and say, oh, things are getting worse, you might be forgetting all the things that went wrong in the past. Andrew Marr: And what we call the news is a long litany of all the things that are getting worse or going wrong. Me: Well, yes, it’s much easier for something bad to happen suddenly than for something good to happen. Good things either creep up on you a few percentage points a year, and sometimes can compound. So the fact that, for example, extreme poverty in the world has been declining and a billion people have escaped extreme poverty over the last 30 years — but not on Thursday — so it was never an event from the news. One of the biggest events in human history is something that most people have never even heard of. @AndrewMarr9 @LBC
168
28
820
101,004
šŸŒ€ New paper out from @JHPsychedelics led by @CeydaSayali. Psychedelics loosen cognitive control acutely and selectively increase cognitive flexibility afterwards. Flexibility is the ability to shift perspectives, update beliefs, and break rigid patterns. DM for PDF.
In our new review, we synthesize behavioral and neuroimaging evidence showing that psychedelics induce a time- and domain-specific modulation of executive function. Acutely, psychedelics disrupt executive functions alongside destabilized brain network dynamics. Post-acutely, they selectively enhance cognitive flexibility with increased activation and connectivity in executive brain networks. While promising, evidence remains limited and future studies must clarify which cognitive effects drive clinical outcomes.
1
4
269
David S. Rosen, PhD retweeted
There is actually something cognitively beneficial to microdosing classic psychedelics (beyond placebo) that the scientific method just hasn’t yet been able to detect.
37%Yes
63%No
19 votes • Final results
1
2
3
300
David S. Rosen, PhD retweeted
Can you believe Empyrean Isles was released 61 years ago this month? We sure can’t! 🤯
25
91
15
747
20,323
David S. Rosen, PhD retweeted
People on psychedelics during a mass-trauma event (Nova rave) reported that psychedelic effects suddenly went away completely and they felt clear and calm. After they reached safety, these survivors described resurgance of vivid hallucinations! The researchers are calling it 'Adaptive dissociation'. An interesting twist on our observation that psychedelic effects are highly context-dependent. When you focus on a task, effects decreased markedly, with stronger effects returning when attention relaxes. šŸ‘‰ Read about the link: psychologytoday.com/us/blog/…
23
32
7
294
16,455
David S. Rosen, PhD retweeted
Check out this awesome new work by Tuval! Providing critical empirical evidence on question asking, knowledge acquisition, and academic assessments
1
1
156
🚨ATTN: Society for Neuroscience attendees @SfNtweets 🚨 We are hosting a pre-SfN event: "The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience" Registration is limited - reserve your spot ASAP! Share with anyone who might be interested! hopkinspsychedelic.org/sfn20…
1
10
3
14
6,043
Looking forward to this excellent pre-#SfN25 event from @JHPsychedelics šŸ‘‡ A rare chance to dive into cross-species translation in psychedelic neuroscience with leading voices in the field. šŸ„ Seats are limited—don’t miss it!
🚨ATTN: @SfNtweets attendees🚨 @JHPsychedelics is hosting a pre-SfN event: "The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience"šŸ„ Registration is limited - reserve your spot ASAP! hopkinspsychedelic.org/sfn20… RTs appreciated! InfošŸ‘‡
1
3
162
Associate Director, Dr. Albert Garcia-Romeu shared his insights on psychedelic therapies for psychiatric disorders. He explains the science, shifting public perception, and potential for future FDA approval for these therapies.
4
21
2
67
5,136
David S. Rosen, PhD retweeted
Are you an early-career cognitive neuroscientist, looking to contribute to a new line of research? The Frontlab at Paris Brain Institute is seeking a postdoctoral researcher to work on a state-of-the-art creativity neuroscience project - offres.institutducerveau-icm…
3
7
548
šŸŽø Mike Gordon’s XenboX is one of the most exciting neuro/music collaborations I’ve seen. A real-time system to detect and enhance flow in musicians? Yes, please. As a musician, neuroscientist & lifelong Phish fan, I had to weigh in. šŸ”— rollingstone.com/music/music… #phish #flow
2
2
6
289
XenboX is bold and inspiring. But understanding and scaling tools for creative flow will require more science—across domains, in the wild, and with personalized models of set and setting. This deeper inquiry is similar to questions we are pursuing in psychedelic science.
1
48
Huge kudos to @mike_gordon & the XenboX team. Merging music, brain tech, and performance science is rare—and visionary. Maybe one day I'll have a chance to help advance this project šŸ¤ž #creativity #music #improvisation #neurofeedback #phish #DMN #braintech #peakperformance
62
David S. Rosen, PhD retweeted
A teacher in Thailand invites her students to pick their greeting. Can we do this in every classroom in every country?
62
198
50
1,473
223,629
My mentors and colleagues representing on Capitol Hill. What an honor to be a part of the CPCR!
Last week, CPCR researchers Drs. Fred Barrett, Brandon Weiss, David Yaden, and Sandeep Nayak met with the PATH Caucus (led by @RepLouCorrea and @RepJackBergman) on Capitol Hill. In a vibrant meeting of oral presentations and Q&A, Drs. Barrett and Weiss shared their scientific findings signaling the potential for Psilocybin Therapy to be a rapid-acting, efficacious, safe, and tolerable tool for treating PTSD, alcohol use disorder, and depression among military Veterans and other Americans. We thank the PATH Caucus for their great advocacy for research on psychedelic therapy and Veteran health, and for including us in their mission. @FredBarrettPhD @BWe1ss @ExistWell @sdpnayak
3
108